skip to content
Alliance for Microbicide Development

Public Sector Entities

Centers for Disease Control and Prevention (CDC)
CDC was founded in 1946 to help control malaria and has remained at the forefront of public health efforts to prevent and control infectious and chronic diseases, injuries, workplace hazards, disabilities, and environmental health threats. CDC is globally recognized for conducting research and investigations and for its action oriented approach. For more information about CDC, visit: http://www.cdc.gov/.

National Institute of Allergy and Infectious Disease (NIAID)
The National Institute of Allergy and Infectious Disease conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. For more information about NIAID, visit: http://www3.niaid.nih.gov/.

  • Division of Acquired Immunodeficiency Syndrome (DAIDS) NIAID's Division of Acquired Immunodeficiency Syndrome was formed in 1986 to address the national research needs created by the HIV/AIDS epidemic. DAIDS' mission is to increase basic knowledge of the pathogenesis, natural history, and transmission of HIV disease and to support research that promotes progress in its detection, treatment, and prevention. For more information about DAIDS, visit: http://www.niaid.nih.gov/daids/daidsover.htm.
  • Division of Microbiology and Infectious Diseases (DMID) NIAID's Division of Microbiology and Infectious Diseases supports extramural research to control and prevent diseases caused by virtually all human infectious agents except HIV. This includes research on emerging and re-emerging infectious diseases, and on NIAID Category A, B, & C priority pathogens. DMID supports a wide variety of projects spanning the spectrum from basic through applied research, along with the development and clinical evaluation of new drugs, vaccines, and diagnostic tools. For more information about DMID, visit: http://www.niaid.nih.gov/dmid/.

National Institute of Child Health and Human Development (NICHD)
The mission of the NICHD is to ensure that every person is born healthy and wanted, that women suffer no harmful effects from reproductive processes, and that all children have the chance to achieve their full potential for healthy and productive lives, free from disease or disability, and to ensure the health, productivity, independence, and well-being of all people through optimal rehabilitation. For more information about NICHD, visit: http://www.nichd.nih.gov/default.htm.

National Institute of Drug Abuse (NIDA)
NIDA's mission is to lead the US in bringing the power of science to bear on drug abuse and addiction. NIDA supports over 85 percent of the world's research on the health aspects of drug abuse and addiction. NIDA-supported science addresses the most fundamental and essential questions about drug abuse, ranging from the molecule to managed care, and from DNA to community outreach research. For more information about NIDA, visit: http://www.nida.nih.gov/NIDAHome.html.

National Institute of Mental Health (NIMH)
The NIMH mission is to reduce the burden of mental illness and behavioral disorders through research on mind, brain, and behavior. This public health mandate demands that we harness powerful scientific tools to achieve better understanding, treatment, and eventually, prevention of these disabling conditions that affect millions of Americans. For more information about NIMH, visit: http://www.nimh.nih.gov/nimhhome/index.cfm

Office of AIDS Research (OAR)
The OAR is responsible for the scientific, budgetary, legislative, and policy elements of the NIH AIDS research program. The OAR promotes collaborative research activities in both domestic and international settings. Utilizing the expertise of non-government scientists and AIDS community representatives, the OAR has conducted the first comprehensive evaluation of the NIH AIDS research program to determine whether it is appropriately designed and coordinated to answer the critical scientific questions which will lead to better treatments, prevention, and a cure for AIDS. For more information about the OAR, visit: http://www.nih.gov/od/oar/.

United States Agency for International Development (USAID)
For more than a decade, USAID has been a global leader in microbicide research and development. Since 2000, USAID has collaborated with the NIH, the CDC, and the FDA to develop and implement the US Government Strategic Plan for Microbicides. Guided by this plan, USAID is committed to supporting the development of safe, effective, acceptable, and affordable microbicide products that are suitable for use in developing-country public sector programs. USAID contributes significantly to the following objectives of the Strategic Plan: preclinical development and evaluation - supporting the discovery, development, and preclinical evaluation of microbicides through investment in the early stages of research; formulation and delivery - developing and assessing safe and acceptable microbicide formulations and modes of delivery; clinical trials - conducting clinical studies of potential microbicides to assess safety, effectiveness, and acceptability in reducing the transmission of HIV and other sexually transmitted infections; behavioral and social science - supporting behavioral and social science research to enhance microbicide development and identify social, cultural, and other factors that might undermine use and continued use; training and infrastructure - building sustainable institutional capacity, training investigators to conduct international research, and accelerating access to microbicides in developing countries. For more information about USAID, visit: http://www.usaid.gov/.